CompletedNCT02653729
CBT for Psychosis Symptoms After a First Episode
About this title
Read the official source — NCT02653729Medication studyAges 18–35Schizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 35 years.
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateSeptember 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 50
- Sponsor
- Aisha Andleeb
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 35 Years
- Official registry ID
- NCT02653729
- Official title
Show the full official title
Cognitive Behaviour Therapy for Psychosis in First Episode Patient and the Outcome of Cognitive Behaviour Therapy on Psychotic Symptoms
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Aisha Andleeb.
Did this study involve medication?
Yes. The study involved medication, including Espidone, Olepra and Donu.
Who was this study for?
Listed age limits: 18 years to 35 years.
Want to explore more studies?
Explore studiesRelated studies
'Songs for Life': Group music therapy for serious and enduring mental illness (SEMI) - a randomised control trial
Ondansetron and brain responses in schizophrenia